|Bid||41.45 x 3200|
|Ask||41.53 x 4000|
|Day's range||41.38 - 42.03|
|52-week range||32.83 - 51.86|
|Beta (5Y monthly)||0.69|
|PE ratio (TTM)||17.72|
|Earnings date||02 Nov 2021|
|Forward dividend & yield||1.56 (3.74%)|
|Ex-dividend date||04 Nov 2021|
|1y target est||N/A|
Authorization for Moderna's (MRNA) COVID-19 vaccine for ages 12-17 was put on hold Friday in light of concerns over a rare side effect known as myocarditis, or a heart inflammation.
Dr. Francis Collins, Outgoing NIH Director, joins Yahoo Finance’s Anjalee Khemlani to discuss Covid-19 vaccine production, drug development research, and misinformation surrounding Covid-19 vaccines.
Despite the recent progress, health officials warn Americans should brace for another wave this winter.